Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade.


Book Description

This study seeks to reinforce the understanding of the interplay between the distinct policy domains of health, trade and intellectual property, and of how they affect medical innovation and access to medical technologies. The second edition comprehensively reviews new developments in key areas since the initial launch of the study in 2013.




Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade


Book Description

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.




Promoting Access to Medical Technologies and Innovation


Book Description

"Public health is a global challenge, and therefore international co-operation has a high priority. The World Health Organization (WHO) is the global authority for health. But a range of other issues are involved in achieving health objectives, requiring WHO to join forces with counterparts. Two of these are the World Intellectual Property Organization (WIPO) and World Trade Organization (WTO). This book is the first ever joint study by the three, part of their collaboration on health, intellectual property, and trade. The book's focus is on advancing medical and health technologies ("innovation") and ensuring they reach the people who need them ("accessibility"). A huge amount of analytical and factual material is available on access to medicines and other medical technologies, and on innovation. Here, it is brought together in one concise volume. The book is designed to support governments and others -- particularly in developing countries -- who face an increasing demand to act, when governments want to increase access to effective treatments while containing costs. The underlying theme is: policies on these issues have to be viewed together in order to make real progress."--Publisher's description.




Promoting Access to Medical Technologies and Innovation


Book Description

Promoting Access to Medical Technologies and Innovation examines the interplay between public health, trade and intellectual property, and how these policy domains affect medical innovation and access to medical technologies. Co-published by the World Health Organization, the World Intellectual Property Organization and the WTO, the study draws together the three Secretariatsņ respective areas of expertise.




Promoting Access to Medical Technologies and Innovation


Book Description

Promoting Access to Medical Technologies and Innovation examines the interplay between public health, trade and intellectual property, and how these policy domains affect medical innovation and access to medical technologies. Co-published by the World Health Organization, the World Intellectual Property Organization and the WTO, the study draws together the three Secretariatsņ respective areas of expertise.




Promoting Access to Medical Technologies and Innovation


Book Description

International cooperation on public health is inherently multi-dimensional, with a focus on building effective health systems. Towards this goal, the World Health Organization (WHO), the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO) have been working closely together, along with other international partners, for almost two decades to support global endeavours to improve health outcomes. As part of their efforts to help countries develop the capacity to deal with multi-dimensional challenges in the public health sector, the three organizations have launched the second edition of the trilateral study on Promoting Access to Medical Technologies and Innovation. Access to essential medicines and the lack of research to address neglected diseases have been a major concern for many years. To promote innovation and to ensure equitable access to all vital medical technologies, such as medicines, vaccines and medical devices, policy-makers need a clear understanding of the innovation processes that lead to new technologies and the ways in which these technologies are disseminated. This publication seeks to improve understanding of the interplay between the distinct policy domains of health, trade and intellectual property, and how they affect medical innovation and access to medical technologies. This second edition captures new developments in key areas since the launch of the first study in 2013. Among the new topics covered in this edition are antimicrobial resistance and cutting-edge health technologies. The publication provides updated data on health, innovation trends in the pharmaceutical sector, and trade and tariffs relating to medical products. It includes an updated overview of access to medical technologies globally and key provisions in regional trade agreements. It also takes account of developments in intellectual property legislation and jurisprudence. Since this study was completed prior to the COVID-19 outbreak, a standalone section on COVID-19 was added at the start of the publication to map the multiple challenges posed by the pandemic in relation to the integrated health, trade and IP policy frameworks set out in the study. It guides the reader to the parts of the main text that are particularly relevant to the issues raised during the pandemic. The publication is the result of a collaborative effort by the WHO, WIPO and the WTO, drawing together the three secretariats' respective areas of expertise. It is intended to inform ongoing technical cooperation activities undertaken by the three organizations and to support policy discussions. Drawing on longstanding experiences in joint technical cooperation activities, the publication has been prepared to serve the needs of policy-makers as well as lawmakers, government officials, delegates to international organizations, non-governmental organizations and researchers.




Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade


Book Description

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.




Promoting Access to Medical Technologies and Innovation - Intersections between public health, intellectual property and trade


Book Description

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.




Promoting Access to Medical Technologies and Innovation - Intersections between public health, intellectual property and trade


Book Description

This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies.




An integrated health, trade and IP approach to respond to the COVID-19 pandemic (update August 30, 2021).


Book Description

The coronavirus disease 2019 (COVID-19) pandemic constitutes an extraordinary global public health crisis that has created a pressing need for intensified global cooperation. This updated information note maps the myriad challenges posed by the outbreak in relation to the integrated health, trade and IP policy frameworks. It provides cross-references to the relevant sections in the updated trilateral study